Brief: Clinical Laserthermia Systems Says Continues To Maintain Targets For 2026
Feb 20 (Reuters) - Clinical Laserthermia Systems AB CLSRb.ST: Q4 NET SALES SEK 830 THOUSAND Q4 OPERATING LOSS SEK 10,615,000 CONTINUES TO MAINTAIN COMMUNICATED TARGETS FOR 2026 Source text: ID:nWkr7mpvvQ Further company coverage: [CLSRb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Clinical Laserthermia Systems AB
See all newsBrief: CLS Enters Research Agreement With U.S. National Cancer Institute
Sweden's CLS Q1 sales fall 72% after partner talks
Brief: Clinical Laserthermia Systems Q1 EBIT Sek 1.7 Mln
Brief: CLS Receives Order Worth SEK 23 Mln For Prism Business
Brief: CLS Expects To Achieve Positive Cash Flow From Q4 2026 To Q1 2028